---
- Enzymatica AB (STO:ENZY) shareholders will have a reason to smile today, with the
analysts making substantial upgrades to next years statutory forecasts. Consensus
estimates suggest investors could expect greatly increasedRead More...
---
- Weve lost count of how many times insiders have accumulated shares in a company
that goes on to improve markedly. Unfortunately, there are also plenty of examples
of share pricesRead More...
---
- It might be of some concern to shareholders to see the Enzymatica AB (STO:ENZY)
share price down 18% in the last month. But that cannot eclipse the spectacular
share priceRead More...
---
- 'Enzymatica ABs (STO:ENZY): Enzymatica AB, a life science company, develops and
sells medical devices for infection-related diseases in Sweden and internationally.
The kr2.1b market-cap posted a loss in its mostRead More...'